Risk of Cardiac Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-Analysis.

Hu, Jiexuan; Tian, Ruyue; Ma, Yingjie; Zhen, Hongchao; Ma, Xiao; Su, Qiang; Cao, Bangwei

Hu, Jiexuan; Tian, Ruyue; Ma, Yingjie; Zhen, Hongchao; Ma, Xiao; Su, Qiang; Cao, Bangwei.

Afiliação

Hu J; Department of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Tian R; Department of Ultrasound, Aero Space Central Hospital, Beijing, China.
Ma Y; Department of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Zhen H; Department of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Ma X; Department of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Su Q; Department of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Cao B; Department of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

Front Oncol ; 11: 645245, 2021.

Article em En | MEDLINE | ID: mdl-34123795

Palavras-chave

PD-1/PD-L1 inhibitors; cardiovascular toxicity; chemotherapy; meta-analysis; solid tumors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google